Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Vitamin B>4< |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Riboflavin |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B>12b< |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing para-aminobenzoic acid (medicinal product) |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Niacinamide |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folic acid |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thioctic acid |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pantothenic acid |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Biotin |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B group poisoning |
Causative agent (attribute) |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
Accidental nicotinic acid derivative poisoning |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Intentional nicotinic acid derivative poisoning |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid derivative poisoning of undetermined intent |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B group adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
Nicotinic acid adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B12 preparation adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Hydroxocobalamin adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinamide adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B complex preparation adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
Inositol adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine preparation adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thiamine preparation adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B group overdose |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
Nicotinic acid derivative overdose |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Accidental nicotinic acid derivative overdose |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Intentional nicotinic acid derivative overdose |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid derivative overdose of undetermined intent |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Poisoning by nicotinic acid derivative |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Levocarnitine |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid adverse reaction |
Causative agent (attribute) |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Choline bitartrate (substance) |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing inositol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing choline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 10mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 10mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 10mg/mL injection solution 2.5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 10mg/mL injection solution 17.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 10mg/mL injection solution 35mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 7.5mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 10mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 3mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 15mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 30mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 3mg/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B group product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely pyridoxine (as pyridoxine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thiamine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thiamine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamins B+C |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B+C strong injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing potassium aminobenzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Potassium aminobenzoate 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Potassium aminobenzoate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B compound tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B compound strong tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing vitamin B complex |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing folinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing pyridoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing thiamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing vitamin B6 compound (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing thiamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing thiamine mononitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid derivatives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 15mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing riboflavin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium aminobenzoate 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Potassium chloride 20meq powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Lovastatin 20 mg and nicotinic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 50mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 50mg/mL injection solution 8mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 50mg/mL injection solution 18mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing lovastatin and nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine hydrochloride 100mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine hydrochloride 100mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine hydrochloride 100mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
acide lévofolinique 50 mg/5 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 375mg m/r tablet and nicotinic acid 500mg m/r tablet and nicotinic acid 750mg m/r tablet starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 750mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 1000mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 15mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Crystalline hydroxocobalamin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing hydroxocobalamin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Hydroxocobalamin 1mg/mL injection 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 50 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|